Medical Fellows in Hematology Awarded Grant To Encourage Research Careers

2012-05-31

(WASHINGTON) – The American Society of Hematology (ASH) today announced the five recipients of the 2012 ASH Research Training Award for Fellows, a grant that encourages junior researchers in hematology-related training programs to pursue careers in academic hematology by providing protected time to conduct research during their fellowship training.

With the goals of promoting mentorship and fostering a new generation of clinical, basic, and translational researchers in hematology, this program provides grants of $50,000 for a one-year period to third- and fourth-year trainees who may one day make important discoveries to advance the treatment of blood disorders.

“ASH has selected some of the most talented trainees in the field for this award and we look forward to seeing the fruits of their medical research efforts over the next year and beyond,” said ASH President Armand Keating, MD, of Princess Margaret Hospital in Toronto. “Our hope is that this program will also help position these promising clinician-scientists to be more competitive when applying for future K award funding once the award period concludes.”

The 2012 ASH Research Training Award for Fellows recipients and their research topics are as follows:

Vivian Chang, MD, UCLA Medical Center
Molecular Analysis of Congenital Acute Lymphoblastic Leukemia

Mathew Cherian, MBBS, Washington University School of Medicine
Mechanisms of Oncogenic Transformation in Adult T-Cell Lymphocytic Leukemia

Gabriel Ghiaur, MD, PhD, The Johns Hopkins University
Role of Retinoic Acid in Human Hematopoietic Stem Cell Biology

Jessica Heath, MD, Duke University Hospital Program
Selective Targeting of CALM-AF10 Leukemias by Iron Modulation

Alexander Ungewickell, MD, PhD, Stanford University
The Role of the Phosphatidylinositol 3-Kinase Pathway in Cutaneous T-Cell Lymphoma

To arrange an interview with an RTAF recipient, please contact Lindsey Love at 202-552-4925 or llove@hematology.org.

The American Society of Hematology is the world’s largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood, the most cited peer-reviewed publication in the field, which is available weekly in print and online.

back to top